Dtsch Med Wochenschr 2013; 138(49): 2539-2542
DOI: 10.1055/s-0033-1349662
Verdauungs- und Stoffwechselkrankheiten | Commentary
Gastroenterologie
© Georg Thieme Verlag KG Stuttgart · New York

Solide Pankreasraumforderungen: Diagnostik und Differenzialdiagnostik

Diagnosis and differential diagnosis of panceatic lesions
A. Arlt
1   Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel
,
M. Ellrichmann
1   Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel
,
S. Schreiber
1   Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel
,
H. Mönig
1   Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. November 2013 (online)

 
  • Literatur

  • 1 Bartsch DK, Gress TM, Langer P. Familial pancreatic cancer – current knowledge. Nat Rev Gastroenterol Hepatol 2012; 9: 445-453
  • 2 Canto MI, Harinck F, Hruban RH et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 2013; 62: 339-347
  • 3 Dawwas MF, Taha H, Leeds JS et al. Diagnostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, single-center study. Gastrointest Endosc 2012; 76: 953-961
  • 4 Falconi M, Bartsch DK, Eriksson B et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 2012; 95: 120-134
  • 5 Grutzmann R, Post S, Saeger HD et al. Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis. Dtsch Arztebl Int 2011; 108: 788-794
  • 6 Hewitt MJ, McPhail MJ, Possamai L et al. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc 2012; 75: 319-331
  • 7 Hocke M, Ignee A, Dietrich CF. Advanced endosonographic diagnostic tools for discrimination of focal chronic pancreatitis and pancreatic carcinoma – elastography, contrast enhanced high mechanical index (CEHMI) and low mechanical index (CELMI) endosonography in direct comparison. Z Gastroenterol 2012; 50: 199-203
  • 8 Jensen RT, Cadiot G, Brandi ML et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 2012; 95: 98-119
  • 9 Kim MK. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut and liver 2012; 6: 405-410
  • 10 Kloppel G, Rindi G, Perren A et al. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 2010; 456: 595-597
  • 11 Saftoiu A, Vilmann P, Gorunescu F et al. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy 2011; 43: 596-603
  • 12 Schott M, Kloppel G, Raffel A et al. Neuroendocrine neoplasms of the gastrointestinal tract. Dtsch Arztebl Int 2011; 108: 305-312
  • 13 Vasile TA, Feier D, Socaciu M et al. Contrast enhanced ultrasound and computer tomography diagnosis of solid and mixed pancreatic tumors – analysis of confounders. J Gastrointest Liver Dis 2012; 21: 285-292
  • 14 Vincent A, Herman J, Schulick R et al. Pancreatic cancer. Lancet 2011; 378: 607-620
  • 15 Zarate X, Williams N, Herrera MF. Pancreatic incidentalomas. Best Pract Res Clin Endocrinol Metab 2012; 26: 97-103